CardiovascularORALStandard
SIMVASTATIN
SIMVASTATIN
Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SIMVASTATIN is listed in Drugs@FDA under application 211394 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SIMVASTATIN Form and strength TABLET;ORAL - 80MG Sponsor YILING Submission history Latest submission status date: 2024-11-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview SIMVASTATIN is listed in Drugs@FDA under application 211394 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SIMVASTATIN Form and strength TABLET;ORAL - 80MG Sponsor YILING Submission history Latest submission status date: 2024-11-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.